Bioanalytical CRO Excellence
Welcome to KCAS Bio, your global bioanalytical CRO partner with the expertise, capacity and flexibility sponsors require.
CRO for preclinical and clinical bioanalysis
KCAS Bio is a leading bioanalytical contract research organization (CRO) with a proven record of advancing drug development worldwide. We have provided bioanalytical development support for more than 315 approved drugs on the market, developed over 6,200 proprietary and non-proprietary assays, and successfully completed more than 20 FDA audits with no major findings.
As a top bioanalytical CRO lab, we continually invest in the latest instrumentation and combine this technical expertise with a consultative approach, ensuring our clients’ goals are achieved with confidence. Our teams also bring specialized expertise in advanced modalities, allowing us to support the evolving needs of modern drug development. By consistently benchmarking and optimizing our operations, we help scientific innovators and investors move forward with greater certainty.
With lab facilities across the US and Europe, along with a strategic alliance in Australia, we provide global sponsors with comprehensive services including bioanalytical, biomarker, immunogenicity, cellular and molecular assay capabilities, as well as clinical kitting and sample management.
Did you Know? We have Harmonized Spectral Flow Cytometry on a Global Scale!
KCAS Bio is the only bioanalytical laboratory with globally harmonized Cytek spectral flow cytometers, with sites in the US, EU and Australia.


![]()



Global biomarker and bioanalytical CRO lab
KCAS Bio is an established bioanalytical CRO with over 45 years of experience. We understand the human and financial impact of drug development delays. Through our unique approach to capacity planning, we combine the right experts with the right instrumentation to keep development moving smoothly. Our clients consider us a reliable partner because we strive to minimize downtime, avoid delays, and keep lead times as short as possible.
Find exactly what you’re looking for
Search for specific services, platforms, instrumentation, or scientific insights.
What our clients say
We consistently earn our clients’ trust based on our reputation for transparency, delivering error-free data and keeping our promises.
KCAS Bio scientific insights
Blogs
Why Cell Stimulation Matters in Flow Cytometry Many flow cytometry users are happy to start an experiment with a general protocol and a question about their specimen: Will my cells make more cytokines or express more markers after activation? In a healthy person, immune cells like B cells, T cells,…
The NULISA™ / Argo™ HT platform is a new, cutting-edge technology with strong potential in ultra-sensitive biomarker detection and targeted proteomics. You can now watch KCAS Bio’s XTalks webinar to learn more about how we leverage this technology for the analysis of low-abundance biomarkers. Abstract In drug…
Events
February 4
- February 4
KCAS Bio is proud to announce our attendance at the Paris Saclay Cancer Cluster (PSCC) Innovation Forum 2026, taking place in Villejuif, France, on February 4, 2026. This event is a one-day oncology-focused meeting centered on innovation, scientific exchange, and ecosystem collaboration. The program includes expert talks on recent breakthroughs…
Advancing great people and great science
We make nurturing new talent a strategic priority, so that teams are dynamic and constantly improving. We provide a supportive environment for continuous learning and training where you can become your best.
Tell us how we can help with your project
We've earned our reputation for delivering reliable, error-free data. We understand the importance of speed, flexibility, and consistency and only make promises we can keep.
